MiniMedTM 770G system discontinuation

As part of our ongoing effort to simplify product offerings and introduce our advanced technology, we have discontinued sales of the MiniMedTM 770G system and shift to our next-generation MiniMedTM 780G system.

The discontinuation dates for these products are as follows:

  • Last MiniMedTM 770G system sale: July 31, 2025
  • End of MiniMedTM 770G insulin pump replacements: December 31, 2026

We encourage you to explore our latest automated insulin delivery system, the MiniMedTM 780G system with Meal DetectionTM technology, to help you manage your diabetes.

Frequently asked questions

Which product will be impacted?

Add icon collapse icon

The MiniMedTM 770G insulin pump was discontinued on July 31, 2025.

What other therapy options are available to replace my MiniMed™ 770G system? How can I make the switch?

Add icon collapse icon

You may be able to upgrade to our latest automated insulin delivery system, the MiniMed™ 780G system. The only system with Meal Detection™ technology† that automatically delivers correction doses every 5 minutes — even when carb counting isn't exact or occasionally a bolus is missed.§

To see your upgrade options, visit Diabetes.shop. For further questions or assistance, contact 1-800-646-4633 (Monday – Friday, 8 a.m. to 5 p.m. CT).

What happens if my MiniMed™ 770G insulin pump is still under warranty?

Add icon collapse icon

You’ll continue to be able to receive a replacement MiniMed™ 770G pump until December 31, 2026. After December 31, 2026, if a MiniMed™ 770G customer needs a replacement due to a malfunction, we will recommend our newest MiniMed™ 780G pump as the primary replacement option (a new prescription will be required, and costs may apply for CGM upgrades).

What happens if my MiniMed™ 770G system is out of warranty?

Add icon collapse icon

Consider upgrading to the MiniMed™ 780G system today to avoid any disruptions in therapy. After December 31, 2026, you’ll need to upgrade to the MiniMed™ 780G pump with our Sales team. However, if a malfunction occurs after December 31, 2026, an out-of-warranty Continuation of Therapy/loaner pump will require a new prescription, which may disrupt therapy. Guardian™transmitter 3 and Guardian™ 3 sensors will continue to be available.

My MiniMed™ 770G pump is broken; can you send me a replacement one?

Add icon collapse icon

MiniMed will continue to support MiniMed™ 770G in-warranty pump replacements until December 31, 2026. If outside of the replacement date, please contact 1-800-646-4633 to discuss your options.

Footnotes

† Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
‡ Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
§ Refers to SmartGuard™ feature. Individual results may vary.

Important Safety Information: MiniMedTM 780G system with SmartGuardTM technology with Instinct sensor, Simplera SyncTM sensor, and GuardianTM 4 sensor

The MiniMedTM 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose vales in the fluid under the skin.

The MiniMedTM 780G System includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM and GuardianTM 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.

WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.

WARNING: Do not use MiniMedTM 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of MiniMedTM 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including accessories and additional important safety information concerning indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.minimed.com/important-safety-information and the appropriate user guide at https://www.minimed.com/support/download-library.

©2026 MiniMed. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. TM*Third–party brands are trademarks of their respective owners.

DreaMed Diabetes is a trademark of DreaMed Diabetes, Ltd. The MiniMedTM 780G system algorithm includes technology developed by DreaMed Diabetes.